Intermede Investment Partners Ltd Sells 4,785 Shares of Synopsys, Inc. $SNPS

by · The Cerbat Gem

Intermede Investment Partners Ltd lowered its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 4.7% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 96,105 shares of the semiconductor company’s stock after selling 4,785 shares during the period. Synopsys makes up about 1.9% of Intermede Investment Partners Ltd’s portfolio, making the stock its 26th biggest position. Intermede Investment Partners Ltd’s holdings in Synopsys were worth $45,142,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. increased its position in Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock valued at $8,970,415,000 after purchasing an additional 3,120,401 shares during the period. Victory Capital Management Inc. increased its holdings in Synopsys by 238.8% during the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after buying an additional 1,990,608 shares during the period. Coatue Management LLC bought a new position in Synopsys in the third quarter worth approximately $892,605,000. Capital Research Global Investors raised its stake in Synopsys by 226.6% in the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after buying an additional 1,751,432 shares in the last quarter. Finally, State Street Corp lifted its holdings in Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after buying an additional 1,493,912 shares during the period. 85.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SNPS. Rosenblatt Securities dropped their target price on Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a research report on Friday, February 20th. Citigroup boosted their target price on shares of Synopsys from $580.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Finally, Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys has a consensus rating of “Hold” and an average price target of $536.00.

Check Out Our Latest Analysis on SNPS

Synopsys Stock Performance

Shares of SNPS stock opened at $524.74 on Monday. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The company has a market cap of $100.52 billion, a PE ratio of 81.48, a PEG ratio of 4.29 and a beta of 1.25. Synopsys, Inc. has a 12-month low of $376.18 and a 12-month high of $651.73. The business’s fifty day simple moving average is $451.00 and its 200-day simple moving average is $451.13.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same period in the previous year, the business earned $3.03 EPS. The firm’s revenue for the quarter was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Analysts expect that Synopsys, Inc. will post 10.28 earnings per share for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).